2015
DOI: 10.1016/j.nbd.2014.10.025
|View full text |Cite
|
Sign up to set email alerts
|

BDNF contributes to the development of neuropathic pain by induction of spinal long-term potentiation via SHP2 associated GluN2B-containing NMDA receptors activation in rats with spinal nerve ligation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
51
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 55 publications
(53 citation statements)
references
References 160 publications
1
51
1
Order By: Relevance
“…Mechanical hypersensitivity, as a behavioral sign of bone cancer pain, was assessed by measuring 50% PWT as described in our previous reports (59,60). The 50% PWT in response to a series of von Frey filament (Stoelting, Wood Dale, IL) was determined by the up-and-down method (61).…”
Section: Behavioral Testsmentioning
confidence: 99%
“…Mechanical hypersensitivity, as a behavioral sign of bone cancer pain, was assessed by measuring 50% PWT as described in our previous reports (59,60). The 50% PWT in response to a series of von Frey filament (Stoelting, Wood Dale, IL) was determined by the up-and-down method (61).…”
Section: Behavioral Testsmentioning
confidence: 99%
“…The fact that chronic ketamine treatment prevented the mechanical hyperalgesia induced by intrathecal BDNF is consistent with previous observations indicating that spinal NMDA receptors, downstream to TrkB signalling, are importantly involved in the behavioural expression of BDNF‐induced central sensitization underlying some chronic pain conditions. In this regard, it has been reported that, in the spinal cord, BDNF triggers phosphorylation of NMDA receptor subunits NR1 (Slack et al., ; Liu et al., ) and NR2B (Ding et al., ) leading to the induction of late, protein‐dependent long‐term potentiation (LTP) in dorsal horn neurons (Zhou et al., ; Liu and Zhou, ), and that these events are mechanistically associated with behavioural pain responsiveness in neuropathic experimental models of chronic pain (Geng et al., ; Ding et al., ). Nevertheless, the anti‐hyperalgesic effect of ketamine on the paw pressure threshold of BDNF‐injected rats was transient and reversible, as indicated by the appearance of mechanical hyperalgesia once the ketamine pump was depleted.…”
Section: Discussionmentioning
confidence: 99%
“…Binding of BDNF to the TrkB receptor cytoplasmic region promotes the activation of the signalling pathways RAS‐ERK, P13K‐Akt and PLCγ1‐PKC (Khan and Smith, ). In adult neurons, activation of these pathways regulates neural response and synaptic function in the dorsal horn output neurons through a variety of neuroplasticity mechanisms (Smith, ), including increased phosphorylation of NMDA receptor subunits NR1 (Slack et al., ; Liu et al., ) and NR2B (Ding et al., ), leading to the induction of late, protein‐dependent long‐term potentiation (LTP) in dorsal horn neurons (Zhou et al., ; Liu and Zhou, ). As a whole, these neuroplastic changes could mechanistically explain BDNF‐mediated central sensitization and the related development of chronic pain.…”
Section: Introductionmentioning
confidence: 99%
“…Cultured microglias or astrocytes were lysed [31] and commercially available ELISA kits were applied to explore the expression of CD11b (Cloud-Clone Corp., Houston, TX, USA) and glial fibrillary acidic protein (GFAP) (Abcam, Cambridge, MA, USA) following manufacturer's instructions. The concentrations of CD11b and GFAP were normalized to the amount of total protein in rat microglias and astrocytes.…”
Section: Enzyme-linked Immunosorbent Assay (Elisa)mentioning
confidence: 99%